Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Hexal vs Prograf in de novo renal transplant recipients
2011-003795-36Phase 4Terminated
- Sponsor
- Novartis
- Start
- Oct 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus (2 arms), sponsored by Novartis. Primary endpoints: Primary endpoint Phase I and Primary endpoint Phase II. Started Oct 2011; status: terminated.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on 2011-003795-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003795-36.